Counterbalancing angiogenic regulatory factors control the rate of cancer progression and survival in a stage-specific manner.
about
Endorepellin laminin-like globular 1/2 domains bind Ig3-5 of vascular endothelial growth factor (VEGF) receptor 2 and block pro-angiogenic signaling by VEGFA in endothelial cellsThe pancreas cancer microenvironmentExtracellular Matrix, a Hard Player in AngiogenesisPredictive model of thrombospondin-1 and vascular endothelial growth factor in breast tumor tissueIntegrin-α5β1 is not required for mural cell functions during development of blood vessels but is required for lymphatic-blood vessel separation and lymphovenous valve formation.AngioMatrix, a signature of the tumor angiogenic switch-specific matrisome, correlates with poor prognosis for glioma and colorectal cancer patientsTumor angiogenesis in the absence of fibronectin or its cognate integrin receptors.Proteolytically Derived Endogenous Angioinhibitors Originating from the Extracellular MatrixNormal Wound Healing and Tumor Angiogenesis as a Game of Competitive Inhibition.Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer.Bone marrow-derived Gr1+ cells can generate a metastasis-resistant microenvironment via induced secretion of thrombospondin-1.LPA/PKD-1-FoxO1 Signaling Axis Mediates Endothelial Cell CD36 Transcriptional Repression and Proangiogenic and Proarteriogenic Reprogramming.Dietary fat overcomes the protective activity of thrombospondin-1 signaling in the Apc(Min/+) model of colon cancer.Thrombospondin-1 Silencing Down-Regulates Integrin Expression Levels in Human Anaplastic Thyroid Cancer Cells with BRAF(V600E): New Insights in the Host Tissue Adaptation and Homeostasis of Tumor MicroenvironmentQuantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression.Natriuretic peptide receptor A signaling regulates stem cell recruitment and angiogenesis: a model to study linkage between inflammation and tumorigenesis.Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway.The accumulation of DNA repair defects is the molecular origin of carcinogenesis.RNA interference-mediated silencing of VEGF and bFGF suppresses endostatin secretion in pancreatic carcinoma cellsSkin basement membrane: the foundation of epidermal integrity--BM functions and diverse roles of bridging molecules nidogen and perlecan.Endostatin gene therapy stimulates upregulation of ICAM-1 and VCAM-1 in a metastatic renal cell carcinoma model.Thrombospondin-1 deficiency causes a shift from fibroproliferative to inflammatory kidney disease and delays onset of renal failure.Hyperglycemia of tumor microenvironment modulates stage-dependent tumor progression and multidrug resistance: implication of cell survival regulatory molecules and altered glucose transport.A Combination of Immune Checkpoint Inhibition with Metronomic Chemotherapy as a Way of Targeting Therapy-Resistant Cancer Cells.Vitamin D and regulation of vascular cell function.
P2860
Q24312922-786061D2-84A6-4A8B-BA71-2656FF733E9AQ27026705-4F840D90-9A22-4793-842B-40F94B941A0EQ28072886-0362D2DC-9225-4DFD-B823-93FB524327C5Q33897971-62E926FE-4F77-4FEA-B7D4-E9746335E5BCQ33963025-CDBC2E85-48D2-48BF-8F45-4599ED434E59Q34665377-F1021B89-FCD7-4A1C-B1B5-7ED6C2D26D52Q35217119-7DC547B8-FFCB-4999-8D57-F0564E8D915DQ35679807-1494D637-45DF-401A-ABAD-93F369B67DDAQ36217588-E78020E6-C540-47EA-B1EF-1DDD359FEE2BQ36550798-409B063C-595E-4702-994D-32C9423C98D6Q36902175-84B460CC-86CD-446A-B9B5-6E1863DB9E64Q36940630-59853065-6D91-4402-BEA2-4B07BA433DFBQ37096252-0E029740-083C-4BE2-8E2B-9CFE66850187Q37353828-A3404A6D-BA34-483B-90BC-63568A7AB762Q37575966-D879C6DA-D69E-4BBE-ACB3-175F7C89106DQ37695537-DD7BA78A-30C4-4CA3-B22D-564559C17EE3Q37723067-52503D51-403D-4BD3-8E89-CFF553362FE6Q38125930-941B7120-60AC-4A25-8211-97DA1AB0A313Q41880317-3FD1CEDE-4D14-412E-9542-CB1177FB0DB5Q42124126-64CA8A59-698B-439D-8045-DC203B0DAB7CQ42833774-58D645C4-94CB-4BE2-8631-46502A2B5572Q43085557-61F65CFD-6969-4E4E-A0C5-649F839DFF00Q43520655-F2970399-C659-49A1-AAC8-07BFEF4698C5Q44423833-12C74D90-0FB1-4625-8AB7-618D88CEAE61Q49917764-246D3527-40E3-4608-B1C0-917C97ADC3F8
P2860
Counterbalancing angiogenic regulatory factors control the rate of cancer progression and survival in a stage-specific manner.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Counterbalancing angiogenic re ...... al in a stage-specific manner.
@ast
Counterbalancing angiogenic re ...... al in a stage-specific manner.
@en
type
label
Counterbalancing angiogenic re ...... al in a stage-specific manner.
@ast
Counterbalancing angiogenic re ...... al in a stage-specific manner.
@en
prefLabel
Counterbalancing angiogenic re ...... al in a stage-specific manner.
@ast
Counterbalancing angiogenic re ...... al in a stage-specific manner.
@en
P2093
P2860
P356
P1476
Counterbalancing angiogenic re ...... al in a stage-specific manner.
@en
P2093
Douglas Hanahan
Hikaru Sugimoto
Jack Lawler
Jessica Pahler
Julie Lively
Kristofer Rubin
Margot Martino
Mary Soubasakos
Masahiro Inoue
P2860
P304
P356
10.1073/PNAS.1105041108
P407
P577
2011-05-27T00:00:00Z